SPC
CL icon

Spirepoint Private Client’s Colgate-Palmolive CL Stock Holding History

Spirepoint Private Client’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$971K Sell
10,595
-261
-2% -$22.8K 0.08% 137
2026
Q1 		$925K Hold
10,856
– – 0.09% 127
2025
Q4 		$858K Buy
10,856
+85
+0.8% +$6.66K 0.08% 126
2025
Q3 		$861K Sell
10,771
-350
-3% -$29.9K 0.09% 127
2025
Q2 		$1.01M Hold
11,121
– – 0.11% 108
2025
Q1 		$1.04M Sell
11,121
-245
-2% -$21.9K 0.14% 89
2024
Q4 		$1.03M Buy
11,366
+1,644
+17% +$157K 0.13% 96
2024
Q3 		$1.01M Sell
9,722
-1
-0% -$102 0.13% 99
2024
Q2 		$944K Buy
+9,723
New +$897K 0.13% 99

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Spirepoint Private Client's CL Position: Q2 2026 in Review

Spirepoint Private Client reduced its Colgate-Palmolive (CL) stake by 2.4% in Q2 2026, selling an estimated $22.8K and leaving 10,595 shares worth $971K. The position accounts for 0.08% of the portfolio, ranked #137.

Spirepoint Private Client first reported a position in CL in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.04M in Q1 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Spirepoint Private Client held 10,595 shares of Colgate-Palmolive worth $971K as of Q2 2026.
  • Spirepoint Private Client sold 261 Colgate-Palmolive shares in Q2 2026, an estimated $22.8K.
  • Colgate-Palmolive made up 0.08% of Spirepoint Private Client's portfolio in Q2 2026, its #137 holding.
  • Spirepoint Private Client first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 9 quarters since.
  • Spirepoint Private Client's Colgate-Palmolive position peaked at $1.04M in Q1 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.